Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
暂无分享,去创建一个
Hong Xu | Matthias Samwald | Kathrin Blagec | Henk-Jan Guchelaar | Rudolf Koopmann | Mandy Crommentuijn-van Rhenen | Inge Holsappel | Cathelijne H. van der Wouden | Lidija Konta | Daniela Steinberger | Enrico Just | Jesse J. Swen | M. Samwald | H. Guchelaar | Kathrin Blagec | J. Swen | L. Konta | C. H. Wouden | D. Steinberger | Inge Holsappel | R. Koopmann | Hong Xu | M. Rhenen | Enrico Just | Rudolf Koopmann
[1] Ching-Hon Pui,et al. PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[2] Christian Nøhr,et al. International health IT benchmarking: learning from cross-country comparisons , 2016, J. Am. Medical Informatics Assoc..
[3] Diane Hauser,et al. The IGNITE network: a model for genomic medicine implementation and research , 2015, BMC Medical Genomics.
[4] Christopher G Chute,et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. , 2014, Mayo Clinic proceedings.
[5] Julie A Johnson,et al. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics. , 2013, Pharmacogenomics.
[6] Henk-Jan Guchelaar,et al. Translating Pharmacogenomics: Challenges on the Road to the Clinic , 2007, PLoS medicine.
[7] M. Relling,et al. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group , 2018, Clinical pharmacology and therapeutics.
[8] Munir Pirmohamed,et al. A Randomized Trial of Genotype-Guided Dosing of Warfarin , 2014 .
[9] Henk-Jan Guchelaar,et al. Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patients. , 2016, Pharmacogenomics.
[10] Xiang Zhou,et al. Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai. , 2017, Pharmacogenomics.
[11] Tracy H. Porter,et al. Seven years after Meaningful Use: Physicians’ and nurses’ experiences with electronic health records , 2017, Health care management review.
[12] Michelle Whirl-Carrillo,et al. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) , 2016, Genetics in Medicine.
[13] Roy Fielding,et al. Architectural Styles and the Design of Network-based Software Architectures"; Doctoral dissertation , 2000 .
[14] Patrick Kierkegaard,et al. Interoperability after deployment: persistent challenges and regional strategies in Denmark. , 2015, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[15] Henk-Jan Guchelaar,et al. Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time. , 2016, European journal of cancer.
[16] M. Relling,et al. Development and use of active clinical decision support for preemptive pharmacogenomics , 2013, Journal of the American Medical Informatics Association : JAMIA.
[17] S. Mallal,et al. HLA-B*5701 screening for hypersensitivity to abacavir. , 2008, The New England journal of medicine.
[18] F. Mostashari. Office of the National Coordinator for Health Information Technology Attention: Governance RFI , 2005 .
[19] Soma Das,et al. Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago “1,200 Patients Project” , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[20] N J Cox,et al. The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics , 2012, Clinical pharmacology and therapeutics.
[21] Kevin B. Johnson,et al. Electronic health record design and implementation for pharmacogenomics: a local perspective , 2013, Genetics in Medicine.
[22] Stijn Heymans,et al. Semantic validation of the use of SNOMED CT in HL7 clinical documents , 2011, J. Biomed. Semant..
[23] Rita Barallon,et al. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. , 2013, The New England journal of medicine.
[24] E. Balas,et al. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success , 2005, BMJ : British Medical Journal.
[25] Aniwaa Owusu Obeng,et al. Clinical pharmacogenetics implementation: Approaches, successes, and challenges , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[26] Megan Doerr,et al. Cleveland Clinic's Center for personalized healthcare: setting the stage for value-based care. , 2014, Pharmacogenomics.
[27] Gianrico Farrugia,et al. Multidisciplinary Model to Implement Pharmacogenomics at the Point of Care , 2016, Genetics in Medicine.
[28] Matthias Samwald,et al. Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study , 2016, PeerJ.
[29] M O Karlsson,et al. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium , 2017, Clinical pharmacology and therapeutics.
[30] E. Clayton,et al. Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project , 2012, Clinical pharmacology and therapeutics.
[31] Charis Eng,et al. Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services , 2016, Pharmacotherapy.
[32] Matthias Samwald,et al. Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available , 2016, PloS one.
[33] Jeffrey C. Hall,et al. The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine Through Electronic Health Records and Genomics–Pharmacogenomics , 2013, Clinical pharmacology and therapeutics.
[34] Patrick Kierkegaard,et al. eHealth in Denmark: A Case Study , 2013, Journal of Medical Systems.
[35] Sowmya R. Rao,et al. Use of electronic health records in U.S. hospitals. , 2009, The New England journal of medicine.
[36] Melissa Rawley-Payne,et al. University of Florida Clinical and Translational Science Institute: Transformation and Translation in Personalized Medicine , 2011, Clinical and translational science.
[37] Henk-Jan Guchelaar,et al. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. , 2015, Gastroenterology.
[38] Keith Marsolo,et al. Practical considerations in genomic decision support: The eMERGE experience , 2015, Journal of pathology informatics.